Days
At A Glance
Speakers
Session Type
Search
Mon 11 Apr 2011
Mon 11
Tue 12 Apr 2011
Tue 12
Wed 13 Apr 2011
Wed 13
Thu 14 Apr 2011
Thu 14
All
Type
No focus area
Workshop
Oral
Expert
Plenary
Catering and Social
Nurse
Other
Symposium
Not specified
Hide all
Show all
Monday 11 April
15 sessions
09:00 - 13:00
Registration
11:00 - 13:00
BONE AND MINERAL SPECIAL INTEREST GROUP
HALL 11
Chairs: M Cooper (Birmingham) & B Evans (Cardiff)
SIG1.1
BONE AND MINERAL SPECIAL INTEREST GROUP
Osteopetrosis and other causes of high bone mass
C Gregson
SIG1.2
BONE AND MINERAL SPECIAL INTEREST GROUP
Hypophosphataemic rickets
T Carpenter
New Haven, USA
SIG1.3
BONE AND MINERAL SPECIAL INTEREST GROUP
Osteogenesis imperfecta
M Cooper
SIG1.4
BONE AND MINERAL SPECIAL INTEREST GROUP
Osteoporosis
A Uitterlinden
Rotterdam, Netherlands
11:00 - 13:00
OBESITY SPECIAL INTEREST GROUP
HALL 1
Chairs: S Aylwin (London) & K Murphy (London)
SIG2.1
OBESITY SPECIAL INTEREST GROUP
Gut hormone based polypharmacy - same benefits without the surgery?
D Perez-Tilve
Cincinatti, USA
SIG2.2
OBESITY SPECIAL INTEREST GROUP
Gut, hormones, weight loss and metabolic improvement after bariatric surgery
T Olbers
SIG2.3
OBESITY SPECIAL INTEREST GROUP
Pre- and post-operative management of patients undergoing bariatric surgery
R Andrews
SIG2.4
OBESITY SPECIAL INTEREST GROUP
Bariatric surgery - a cure for diabetes?
D Johnson
11:00 - 13:00
LABORATORY ASPECTS OF CLINICAL ENDOCRINOLOGY (LACE) SPECIAL INTEREST GROUP
HALL 9
Chairs: J Barth (Leeds) & R Gorrigan (London)
SIG3.1
LABORATORY ASPECTS OF CLINICAL ENDOCRINOLOGY (LACE) SPECIAL INTEREST GROUP
Definition of Vitamin D deficiency
J Walsh
SIG3.2
LABORATORY ASPECTS OF CLINICAL ENDOCRINOLOGY (LACE) SPECIAL INTEREST GROUP
Definition of male hypogonadism
C Wang
Torrence, USA
SIG3.3
LABORATORY ASPECTS OF CLINICAL ENDOCRINOLOGY (LACE) SPECIAL INTEREST GROUP
Definition of hypothyroidism
G Beckett
SIG3.4
LABORATORY ASPECTS OF CLINICAL ENDOCRINOLOGY (LACE) SPECIAL INTEREST GROUP
Definition of hyperandrogenism
J Barth
13:00 - 13:30
LUNCH
HALL 3
13:30 - 15:30
Symposium 1
ALL YOU NEED TO KNOW ABOUT THE GENETICS OF DIABETES (TYPE 1 & 2 AND MODY)
HALL 11
Chairs: S Farooqi (Cambridge) & S Finer (London)
S1.1
Symposium 1
Immune mechanisms involved in Type 1 diabetes - insights from genetics
V Plagnol
S1.2
Symposium 1
The diverse phenotypes of potassium ATP channel mutations
S Ellard
S1.3
Symposium 1
Using biomarkers to differentiate subtypes of MODY
K Owen
S1.4
Symposium 1
Genome-wide association studies for Type 2 diabetes
J Perry
13:30 - 15:30
Clinical Management Workshop 1
THE MANAGEMENT OF DIFFICULT GRAVES' DISEASE
SUPPORTED BY CLINICAL ENDOCRINOLOGY AND THYROID EYE DISEASE CHARITABLE TRUST
HALL 1
Chairs: R Ajjan (Leeds) & T Galliford (London)
CM1.1
Clinical Management Workshop 1
Autoimmune hyperthyroidism - a spectrum of causes
S Pearce
Newcastle, UK
CM1.2
Clinical Management Workshop 1
Thyroid storm, aranulocytosis, vasculitis, hepatitis - what to do next?
A Allahabadia
CM1.3
Clinical Management Workshop 1
The management of Graves' opthalmopathy and dermopathy
L Bartalena
Varese, Italy
CM1.4
Clinical Management Workshop 1
New therapies for Graves' Disease
C Dayan
13:30 - 15:30
Applied Physiology Workshop
SEEING IS BELIEVING - CUTTING EDGE IN VIVO CELL IMAGING
HALL 9
Chairs: J Davis (Manchester) & M Gurnell (Cambridge)
AP1.1
Applied Physiology Workshop
Cellular imaging in the pituitary - in vivo confocal microscopy
P Mollard
Montpellier, France
AP1.2
Applied Physiology Workshop
Imaging of cell migration and invasion
P Friedl
Nijmegen, Netherlands
AP1.3
Applied Physiology Workshop
CARS microscopy as a novel tool in cell imaging
S Mahajan
15:30 - 16:00
TEA & COFFEE
HALL 3
16:00 - 18:00
Symposium 2
NOVEL PATHWAYS AND TREATMENTS IN NEUROENDOCRINE TUMOURS
SUPPORTED BY THE ASSOCIATION FOR MULTIPLE ENDOCRINE NEOPLASIA DISORDERS
HALL 11
Chairs: P Trainer (Manchester) & U Srirangalingam (London)
S2.1
Symposium 2
Signalling pathways in neuroendocrine tumours
M Kidd
New Haven, USA
S2.2
Symposium 2
DNA methylation profiling of neuroendocrine tumours
C Thirwell
S2.3
Symposium 2
Tyrosine kinase inhibitors for neuroendocrine tumours
J Valle
S2.4
Symposium 2
New horizons in therapy
D Hochhauser
16:00 - 18:00
Oral Communications 1
YOUNG ENDOCRINOLOGISTS' PRIZE SESSION
HALL 1
Chairs: I Clarke (Melbourne, Australia) & J Fagin (New York, NY, USA)
OC1.1
Oral Communications 1
Thyroid hormones in the euthyroid range predict subsequent body mass composition in women - the OPUS study
P Rao
OC1.2
Oral Communications 1
Does ‘mild’ primary hyperparathyroidism progress if left untreated? A natural history study
OC1.3
Oral Communications 1
Prolonged exposure to growth hormone (GH) impairs insulin signalling in the heart
OC1.4
Oral Communications 1
Developing an in vitro model of tissue expansion in Graves ophthalmopathy - exploring the role of IGF-1 receptor targeting as a novel treatment.
OC1.5
Oral Communications 1
Athertoprotection by 11β-HSD1 deficiency in APOE-/- mice - role of both glucocorticoid and 7-oxysterol factors
OC1.6
Oral Communications 1
Evidence for the existence and significance of an alternative pathway towards androgen synthesis during early human life
OC1.7
Oral Communications 1
Mutant cytochrome b5 causing 46,XY disorder of sex development (DSD) due to apparent CYP17A1 17,20 lyase
OC1.8
Oral Communications 1
TSH levels and thyroid hormone prescribing in primary care in the UK
16:00 - 18:00
Oral Communications 2
STEROIDS
HALL 9
Chairs: S Hillier (Edinburgh) & M De Bono (Sheffield)
OC2.1
Oral Communications 2
Regulation of 11beta-hydroxysteroid dehydrogenase type 1 by NF-kB in stromal cells - towards tissue specific enzyme
OC2.2
Oral Communications 2
Anti-inflammatory mechanisms of 5α-Reduced glucocorticoids - potential dissociated steroids
OC2.3
Oral Communications 2
APEX1, a novel, negative regulator of aldosterone synthase activity, differentially binds to a single nucleotide polymorphism in the aldosterone synthase gene and represses transcriptional activity both in vitro and in vivo
OC2.4
Oral Communications 2
Altered miR-125 and miR-134 expression in aldosterone-producing adenoma and post-transcriptional regulation of the CYP11B2 gene
OC2.5
Oral Communications 2
A novel entity of isolated adrenal insufficiency caused by partial inactivation of P450 side-chain cleavage (CYP11A1) enzyme
OC2.6
Oral Communications 2
Novel non-steroidal glucocorticoids that dissociate rapid signalling effects from gene transcription
OC2.7
Oral Communications 2
Depot specific differences in the sensitivity to glucocorticoid and insulin action in human adipose tissue
OC2.8
Oral Communications 2
Metformin increases in vivo 11β-hydroxysteroid dehydrogenase type 1 activity in euglycaemic obese men
18:10 - 19:10
YOUNG ENDOCRINOLOGISTS' PRIZE LECTURES
HALL 1
Chairs: A McNeilly (Edinburgh) & P Trainer (Manchester)
YEP1.1
YOUNG ENDOCRINOLOGISTS' PRIZE LECTURES
Novel glucocorticoid effects - signaling from the membrane to the nucleus
L Matthews
YEP1.2
YOUNG ENDOCRINOLOGISTS' PRIZE LECTURES
Clinical, genetic and molecular characterisation of patients with familial isolated pituitary
H Chalal
19:15 - 23:00
WELCOME RECEPTION
HALL 3
19:45 - 23:00
YE SOCIAL EVENING
HALL 11
Tuesday 12 April
22 sessions
07:00 - 07:15
Breakfast
HALL 9, 10 & 11 FOYER
07:15 - 08:00
Meet the Expert 1
ABNORMAL GROWTH AND PUBERTY PRESENTING IN 'LATE ADOLESCENCE'
SUPPORTED BY CLINICAL ENDOCRINOLOGY
HALL 9
Chair: H Gleeson (Manchester)
Expert: P Clayton (Manchester)
07:15 - 08:00
Meet the Expert 2
THE DIFFICULT CUSHING'S OR NELSON'S PATIENT
SUPPORTED BY CLINICAL ENDOCRINOLOGY
HALL 11
Chair: A Grossman (London)
Expert: X Bertanga (Paris, France)
07:15 - 08:00
Meet the Expert 3
VITAMIN D DEFICIENCY, WHEN AND HOW TO TREAT
SUPPORTED BY CLINICAL ENDOCRINOLOGY
HALL 10
Chair: S Orme (Leeds)
Expert: P Selby (Manchester)
08:15 - 10:15
Symposium 3
FAT ENDOCRINOLOGY: DISORDERS OF ADIPOSE TISSUE AND LIPIDS IMPORTANT TO THE ENDOCRINOLOGIST
HALL 1
Chairs: W Dhillo (London) & A Sam (London)
S3.1
Symposium 3
Can we make more brown adipose tissue to treat obesity?
W Lichtenbelt
Maastrict, Netherlands
S3.2
Symposium 3
Familial partial lipodystrophy - an introduction and the importance of diagnosing FPLD
S Suliman
S3.3
Symposium 3
The link between insulin resistance, dyslipidaemia and fatty liver
Robert Semple
Edinburgh, UK
S3.4
Symposium 3
What you need to know about the genetics of hyperlipidaemia
C Shoulders
08:15 - 10:15
Oral Communications 3
PITUITARY AND THYROID
HALL 9
Chairs: P Belchetz (Leeds) & A Mitchell (Newcastle)
OC3.1
Oral Communications 3
Development of a novel mass spectroscopy-based method for determining serum IGF-1 - assessment in a cohort of newly diagnosed subjects with acromegaly.
OC3.2
Oral Communications 3
Determination of method-specific normal cortisol responses to the short Synacthen test
OC3.3
Oral Communications 3
miR-107 inhibits the expression of aryl hydrocarbon receptor interacting protein (AIP) and is potentially involved in pituitary tumorigenesis
OC3.4
Oral Communications 3
PTTG promotes mitogenic mechanisms in thyroid cells through autocrine pathways of interaction with growth factors
OC3.5
Oral Communications 3
Metastatic characteristics and radiosensitivity of thyroid carcinoma cells depends on HIF-1 and PI3K signalling in vitro and in vivo
OC3.6
Oral Communications 3
Morbidity in patients with endogenous subclinical hyperthyroidism
OC3.7
Oral Communications 3
Thyroid dysfunction and clot structure - a mechanism for increased thrombotic risk in hyperthyroid individuals?
OC3.8
Oral Communications 3
Assessment of the UK iodine status - a national survey
08:15 - 10:15
Clinical Management Workshop 2
ENDOCRINE PROBLEMS IN PREGNANCY
SUPPORTED BY CLINICAL ENDOCRINOLOGY, THE BRITISH THYROID FOUNDATION AND ADDISON'S DISEASE SELF HELP GROUP
HALL 11
Chairs: T Kearney (Manchester) & S Jarvis (London)
CM2.1
Clinical Management Workshop 2
Hypothyroidism and euthyroid antibody-positive patients
S Chan
CM2.2
Clinical Management Workshop 2
Treatment of hyperthyroidism in pregnancy-risk for the unborn
M Clementi
Padova, Italy
CM2.3
Clinical Management Workshop 2
Adrenal disorders in pregnancy
W Arlt
CM2.4
Clinical Management Workshop 2
Phaeochromocytoma in pregnancy
J Lenders
Nijmegen, Netherlands
10:15 - 10:40
TEA & COFFEE
HALL 3
10:40 - 11:20
SOCIETY FOR ENDOCRINOLOGY DALE MEDAL LECTURE
HALL 1
Chair: J Buckingham (London)
PL1
SOCIETY FOR ENDOCRINOLOGY DALE MEDAL LECTURE
Aromatase, obesity and breast cancer - old wine in new bottles
E Simpson
Melbourne, Australia
11:20 - 12:00
SOCIETY FOR ENDOCRINOLOGY HOFFENBERG INTERNATIONAL MEDAL LECTURE
HALL 1
Chair: M Korbonits (London)
PL2
SOCIETY FOR ENDOCRINOLOGY HOFFENBERG INTERNATIONAL MEDAL LECTURE
Aldosterone action and the mineralocorticoid receptor
P Fuller
Melbourne, Australia
12:00 - 14:00
LUNCH & POSTERS
HALL 3
14:00 - 16:00
Symposium 4
ENDOCRINE REGULATION OF AGEING
HALL 10
Chairs: J Kopchick (Athens, GA, USA) & C Moss (London)
S4.1
Symposium 4
The aging process - somatotrophic axis and calorie restriction
A Bartke
Springfield, USA
S4.2
Symposium 4
Mechanisms: insulin sensitivity, AMPK and lifespan
C Selman
S4.3
Symposium 4
DHEA, DHEAS and immunosenescence
J Lord
S4.4
Symposium 4
Aging, hormones and cognition in humans
A MacLullich
14:00 - 16:00
Oral Communications 4
BONE, METABOLISM AND DIABETES
HALL 11
Chair: P Newey (Oxford)
OC4.1
Oral Communications 4
A mouse with an ENU-induced mutation (Tyr209Asn) in the Natriuretic peptide receptor 3 (Npr3) develops autosomal recessive kyphosis
OC4.2
Oral Communications 4
Is MEPE a novel regulator of growth plate mineralisation?
OC4.3
Oral Communications 4
Rapid bone turnover responses to increased hypothalamic-pituitary-thyroid-axis activity are mediated by thyroid hormones
OC4.4
Oral Communications 4
CB1 receptor mediates the effects of glucocorticoids on AMPK activity in the hypothalamus but not in adipose tissues
OC4.5
Oral Communications 4
Alterations to hypothalamic 5-HT and DA turnover in offspring induced by maternal exposure to a high caloric diet throughout lactation
OC4.6
Oral Communications 4
Dual effect of arachidonic acid on peroxisome proliferator-activated receptor gamma (PPARg)-dependent action in 3T3-L1 adipocytes
OC4.7
Oral Communications 4
Co-administration of the gut hormones PYY and GLP-1 to human volunteers reduces food intake and brain activation in appetite centres
OC4.8
Oral Communications 4
Hyperghrelinaemia, hyperphagia, food hoarding and reduced adiposity in an imprinting centre deletion mouse model of Prader Willi syndrome
14:00 - 16:00
Young Endocrinologists' Symposium
A SUCCESSFUL RESEARCH CAREER
HALL 9
Chairs: L Lloyd (Nottingham) & A Tahrani (Birmingham)
YE1.1
Young Endocrinologists' Symposium
Research in clinical academia
M Bono
YE1.2
Young Endocrinologists' Symposium
Managing your research degree
A McNeilly
YE1.3
Young Endocrinologists' Symposium
Postdoctoral research - the things I wish I knew
A Hanyaloglu
YE1.4
Young Endocrinologists' Symposium
Commercialisation and IP – translating scientific research
S Webster
16:00 - 16:30
TEA & COFFEE
HALL 3
16:30 - 18:30
Oral Communications 5
REPRODUCTION AND FOETAL PROGRAMMING
HALL 10
Chairs: A Fowden (Cambridge) & S Chan (Birmingham)
OC5.1
Oral Communications 5
The effect of a maternal low protein diet on renal development and function in the offspring
OC5.2
Oral Communications 5
Maternal low protein diet and fetal growth restriction - new insights into the role of placental 11ß-hydroxysteroid dehydrogenase-2
OC5.3
Oral Communications 5
Mutations in the gene encoding the Fibroblast Growth Factor 8 (FGF8) are associated with complex midline defects including recessive holoprosencephaly and hypothalamo-pituitary dysfunction
OC5.4
Oral Communications 5
Impaired cardiac function in GR-/- fetal mice
OC5.5
Oral Communications 5
Absence of 11β-HSD2 specifically within the foetal brain alters adult 'depressive' behaviour
OC5.6
Oral Communications 5
Consequence of embryonic exposure to 17β-estradiol on brain asymmetry development and neuroendocrine gene
OC5.7
Oral Communications 5
Plasma biomarkers for early prediction of preleclampsia
OC5.8
Oral Communications 5
Altered fetoplacental growth in monocarboxylate transporter 8 (Mct8) knockout mice
16:30 - 18:30
Symposium 5
THE NOVEL ROLE OF PRIMARY CILIA IN ENDOCRINE DISEASE AND OBESITY
HALL 9
Chairs: P Chapple (London) & L Guasti (London)
S5.1
Symposium 5
Primary cilia in health and disease
Philip Beales
London, UK
S5.2
Symposium 5
The importance of primary cilia in adrenal development
P King
S5.3
Symposium 5
The importance of primary cilia in adipogenic differentiation
V Marion
Strasbourg, France
S5.4
Symposium 5
Primary cilia dysfunction causes impaired leptin signalling and obesity
V Sheffield
Iowa City, USA
16:30 - 17:30
Clinical Debate
THIS HOUSE BELIEVES THAT THERE IS AN IMPORTANT ROLE FOR BONE MARKERS IN THE CLINICAL MANAGEMENT OF PATIENTS WITH OSTEOPOROSIS
HALL 1
Chair: R Eastell (Sheffield)
For: W Fraser (Liverpool) & Against: A McLellan (Glasgow)
D1.2
Clinical Debate
This house believes there is an important role for bone markers in the clinical management of patients with osteoporosis
B Fraser
D1.1
Clinical Debate
This house believes there is an important role for bone markers in the clinical management of patients with osteoporosis
A McLellan
17:30 - 18:15
Meet the Expert 1 (repeat)
ABNORMAL GROWTH AND PUBERTY PRESENTING IN 'LATE ADOLESCENCE'
SUPPORTED BY CLINICAL ENDOCRINOLOGY
HALL 11
Chair: H Gleeson (Manchester)
Expert: P Clayton (Manchester)
17:30 - 18:15
Meet the Expert 2 (repeat)
THE DIFFICULT CUSHING'S OR NELSON'S PATIENT
SUPPORTED BY CLINICAL ENDOCRINOLOGY
HALL 1
Chair: A Grossman (London)
Expert: X Bertanga (Paris, France)
18:30 - 19:00
SOCIETY FOR ENDOCRINOLOGY TRANSATLANTIC MEDAL
HALL 1
Chair: P Stewart (Birmingham)
PL3
SOCIETY FOR ENDOCRINOLOGY TRANSATLANTIC MEDAL
Growth hormone (GH), GH antagonists, GH receptor knockouts; getting old and fat
J Kopchick
19:30 - 23:00
CONFERENCE DINNER
HALL 4
Wednesday 13 April
20 sessions
07:15 - 08:00
Meet the Expert 4
MANAGING TURNER SYNDROME THROUGH CHILDHOOD AND ADOLESCENCE
SUPPORTED BY CLINICAL ENDOCRINOLOGY
HALL 11
Chair: D Dunger (Cambridge)
Expert: M Donaldson (Glasgow)
07:15 - 08:00
Meet the Expert 5
LATE EFFECTS OF CANCER THERAPYY MANAGING THE SILENT EPIDEMIC OF ENDOCRINOPATHIES IN CANCER SURVIVORS
SUPPORTED BY CLINICAL ENDOCRINOLOGY
HALL 10
Chair: A Toogood (Birmingham)
Expert: R Ross (Sheffield)
08:10 - 08:55
SOCIETY FOR ENDOCRINOLOGY ANNUAL GENERAL MEETING
HALL 1
09:00 - 11:00
Symposium 6
NOVEL APPLICATION OF THYROID HORMONE ANALOGUES - THYROID HORMONES, THINKING OUTSIDE THE CAPSULE
HALL 11
Chairs: M Vanderpump (London) & V Smith (Birmingham)
S6.1
Symposium 6
Thyroid hormone action - genomic and non-genomic effects
D Bassett
S6.2
Symposium 6
Physiology and pharmacology of iodothyronamines (thyroid hormone metabolites)
T Scanlan
Portland, USA
S6.3
Symposium 6
The action of thyroid hormone in vascular tissues
P Davis
New York, USA
S6.4
Symposium 6
Liver-selective TR agonists for the treatment of dyslipidemia
B Angelin
Stockholm, Sweden
09:00 - 11:00
Symposium 7
EAT, BOND, REPRODUCE, WHAT THE HYPOTHALAMUS DICTATES
HALL 1
Chairs: G Leng (Edinburgh) & C Jayasena (London)
S7.1
Symposium 7
Vasopressin and social bonding: the role of the olfactory bulb
M Ludwig
S7.2
Symposium 7
The role of tanycytes in the regulation of the reproductive axis
V Prevot
Lille, France
S7.3
Symposium 7
Metabolic regulation of the reproductive axis
I Clarke
Melbourne, Australia
S7.4
Symposium 7
Neurokinin B, kisspeptin and the regulation of puberty
V Navarro
Washington, USA
09:00 - 11:00
Nurses Session 1
TURNER/KLINEFELTER'S/NOONAN'S SYNDROME
SUPPORTED BY KLINEFELTER'S SYNDROME ASSOCIATION
HALL 10
Chairs: S Llahana (London) & K Powell (Norfolk)
N1.1
Nurses Session 1
Turners/Klinefelters/Noonans Syndrome
G Conway
N1.2
Nurses Session 1
Klinefelter's case presentation
P Pickett
N1.3
Nurses Session 1
Living with TS: an adult viewpoint
H Cleaver
N1.4
Nurses Session 1
Klinefelter's Syndrome Association
S Cook
11:00 - 11:30
TEA & COFFEE
HALL 3
11:30 - 12:05
SOCIETY FOR ENDOCRINOLOGY EUROPEAN MEDAL LECTURE 2010
HALL 1
Chair: P Stewart (Birmingham)
PL4
SOCIETY FOR ENDOCRINOLOGY EUROPEAN MEDAL LECTURE 2010
Adrenal lumps and bumps – progress in the management of adrenocortical tumours
Bruno Allolio
Würzburg, Germany
12:05 - 12:40
SOCIETY FOR ENDOCRINOLOGY EUROPEAN MEDAL LECTURE 2011
HALL 1
Chair: G Williams (London)
PL5
SOCIETY FOR ENDOCRINOLOGY EUROPEAN MEDAL LECTURE 2011
Adrenal interlinking in Europe
X Bertagna
Paris, France
12:40 - 14:15
LUNCH & POSTERS
HALL 3
14:15 - 16:15
Symposium 8
HORMONES AND BONE METABOLISM
HALL 11
Chairs: S Orme (Leeds) & M Aye (Kingston-upon-Hull)
S8.1
Symposium 8
Fracture risk in patients with diabetes
L Hofbauer
Dresden, Germany
S8.2
Symposium 8
Muscle weakness, falls and vitamin D deficiency
T Masud
S8.3
Symposium 8
Effects of male hypogonadism on bone metabolism
J Kaufman
Gent, Belgium
S8.4
Symposium 8
Protecting bone density during aromatase inhibitor therapy
R Coleman
14:15 - 16:15
Clinical Management Workshop 3
PITUITARY RADIOTHERAPY: WHAT ARE THE OPTIONS
SUPPORTED BY CLINICAL ENDOCRINOLOGY AND THE PITUITARY FOUNDATION
HALL 1
Chairs: W Drake (London) & M Sherlock (Birmingham)
CM3.1
Clinical Management Workshop 3
Fractionated RT: efficacy and recent advances
M Brada
CM3.2
Clinical Management Workshop 3
Focussed radiotherapy as primary treatment for pituitary disease
J Rowe
CM3.3
Clinical Management Workshop 3
Focussed radiotherapy as salvage treatment for pituitary disease
F Swords
CM3.4
Clinical Management Workshop 3
Radiotherapy, cognition and cerebrovascular disease: what is the evidence?
John Ayuk
Birmingham
14:15 - 16:15
Nurses' Session 2
HYPERTHYROIDISM
HALL 10
Chairs: N Kieffer (Leicester) & J Munday (Portsmouth)
N2.1
Nurses' Session 2
Overview of causes and treatment options
J Franklyn
N2.2
Nurses' Session 2
Nurse led thyroid clinic
V Sanderson
N2.3
Nurses' Session 2
Case presentation
D Wright
N2.4
Nurses' Session 2
Hyperthyroidism
D Papadopoulou
14:15 - 15:00
Meet the Expert 8
APPLICATIONS OF NEXT GENERATION SEQUENCING
HALL 9
Chair: L Metherell (London)
Expert: D Buck (Oxford)
15:15 - 16:15
Meet the Expert 9
MICRORNAS - WHAT ARE THEY, HOW TO MEASURE AND MANIPULATE THEM?
HALL 9
Chair: P Igaz (Budapest, Hungary)
Expert: L O'Driscoll (Dublin, Ireland)
16:15 - 16:45
TEA & COFFEE
HALL 3
16:45 - 17:20
SOCIETY FOR ENDOCRINOLOGY MEDAL LECTURE
HALL 1
Chair: J Buckingham (London)
PL6
SOCIETY FOR ENDOCRINOLOGY MEDAL LECTURE
The bare bones of thyroid hormones
G Williams
17:20 - 17:50
AWARDS CEREMONY
HALL 1
Chair: J Buckingham (London)
18:00 - 18:35
BRITISH THYROID ASSOCIATION PITT-RIVERS LECTURE
SUPPORTED BY THE CLINICAL ENDOCRINOLOGY TRUST
HALL 1
Chair: J Franklyn (Birmingham)
PL7
BRITISH THYROID ASSOCIATION PITT-RIVERS LECTURE
An expanded view on resistance to thyroid hormone
S Refetoff
Chicago, USA
18:35 - 20:35
Satellite sessions
Thursday 14 April
14 sessions
07:30 - 08:15
Meet the Expert 6
ASSESSING THE FRACTURE RISK AND RESPONSE TO THERAPY IN OSTEOPOROSIS
SUPPORTED BY CLINICAL ENDOCRINOLOGY
HALL 11
Chair: A McLellan (Glasgow)
Expert: E McCloskey (Sheffield)
07:30 - 08:15
Meet the Expert 7
MANAGING INFERTILITY
SUPPORTED BY CLINICAL ENDOCRINOLOGY
HALL 9
Chair: A Coomarasamy (Birmingham)
Expert: S Lavery (London)
08:30 - 09:00
CLINICAL ENDOCRINOLOGY TRUST VISITING PROFESSOR LECTURE
SUPPORTED BY THE CLINICAL ENDOCRINOLOGY TRUST
HALL 1
Chair: A Weetman (Sheffield)
PL8
CLINICAL ENDOCRINOLOGY TRUST VISITING PROFESSOR LECTURE
Genetics of thyroid cancer: clinical and therapeutic implications
J Fagin
09:00 - 09:30
CLINICAL ENDOCRINOLOGY TRUST LECTURE
SUPPORTED BY THE CLINICAL ENDOCRINOLOGY TRUST
HALL 1
Chair: S Judd (Adelaide, Australia)
PL9
CLINICAL ENDOCRINOLOGY TRUST LECTURE
Pituitary tumours: the goal is shrinking
J Bevan
09:30 - 10:15
CLINICAL GUIDELINES
HALL 1
Chair: P Trainer (Manchester)
CG1.1
CLINICAL GUIDELINES
Management of pituitary apoplexy
J Wass
10:15 - 10:45
TEA & COFFEE
HALL 3
10:45 - 12:45
Clinical Management Workshop 4
MANAGEMENT OF DISORDERS OF SEX DEVELOPMENT (DSD) ACROSS THE LIFESPAN
SUPPORTED BY CLINICAL ENDOCRINOLOGY AND TURNER SYNDROME SUPPORT SOCIETY
HALL 11
Chairs: F Ahmed (Glasgow) & J Idkowiak (Birmingham)
CM4.1
Clinical Management Workshop 4
The clinical spectrum of DSD
I Hughes
CM4.2
Clinical Management Workshop 4
Presentation in adolescence
O Hiort
Lubeck, Germany
CM4.3
Clinical Management Workshop 4
Transitional care of the young person with DSD
G Conway
CM4.4
Clinical Management Workshop 4
New approaches to molecular diagnosis
J Achermann
London, UK
10:45 - 12:45
Symposium 9
DOPING PERFORMANCE ENHANCING SUBSTANCES IN SPORT AND THEIR DETECTION
HALL 1
Chairs: D Cowan (London) & A Taylor (Birmingham)
S9.1
Symposium 9
Anabolic steroids
A Kicman
S9.2
Symposium 9
Compounds enhancing oxygen delivery
P Hemmersbach
Oslo, Norway
S9.3
Symposium 9
Growth hormone
R Holt
S9.4
Symposium 9
Detection: gene and cellular technologies
T Friedmann
San Diego, USA
10:45 - 12:45
SENIOR ENDOCRINOLOGISTS' SESSION
HALL 9
Chairs: D Anderson (Montecastello di Vibio, Italy) & G Vinson (London)
SE1.1
SENIOR ENDOCRINOLOGISTS' SESSION
The metamorphosis of testosterone from a sex steroid to a universal health factor
E Nieschlag
Muenster, Germany
SE1.2
SENIOR ENDOCRINOLOGISTS' SESSION
Will we ever discover the mechanism of hormone action?
J Tata
SE1.3
SENIOR ENDOCRINOLOGISTS' SESSION
An exploration of colour theory
P Belchetz
SE1.4
SENIOR ENDOCRINOLOGISTS' SESSION
Two seminal case reports of the law breaking the law
D Anderson
Montecastello di Vibio, Italy
SE1.5
SENIOR ENDOCRINOLOGISTS' SESSION
The art of medicine
A Toft
SE1.6
SENIOR ENDOCRINOLOGISTS' SESSION
The endocrinology of extra-marital affairs
G Vinson
12:45 - 13:30
Meet the Expert 3 (repeat)
VITAMIN D DEFICIENCY, WHEN AND HOW TO TREAT
SUPPORTED BY CLINICAL ENDOCRINOLOGY
HALL 11
Chair: S Orme (Leeds)
Expert: P Selby (Manchester)
12:45 - 13:30
Meet the Expert 4 (repeat)
MANAGING TURNER SYNDROME THROUGH CHILDHOOD AND ADOLESCENCE
SUPPPORTED BY CLINICAL ENDOCRINOLOGY
HALL 1
Chair: D Dunger (Cambridge)
Expert: M Donaldson (Glasgow)
12:45 - 13:30
Meet the Expert 5 (repeat)
LATE EFFECTS OF CANCER THERAPY MANAGING THE SILENT EPIDEMIC OF ENDOCRINOPATHIES IN CANCER SURVIVORS
SUPPORTED BY CLINICAL ENDOCRINOLOGY
HALL 9
Chair: A Toogood (Birmingham)
Expert: R Ross (Sheffield)
13:30 - 14:15
Meet the Expert 6 (repeat)
ASSESSING FRACTURE RISK AND RESPONSE TO THERAPY IN OSTEOPOROSIS
SUPPORTED BY CLINICAL ENDOCRINOLOGY
HALL 11
Chair: A McLellan (Glasgow)
Expert: E McCloskey (Sheffield)
13:30 - 14:15
Meet the Expert 7 (repeat)
MANAGING INFERTILITY
SUPPORTED BY CLINICAL ENDOCRINOLOGY
HALL 1
Chair: A Coomarasamy (Birmingham)
Expert: S Lavery (London)
J Achermann
London, UK
Thu 14
12:15
CM4.4
Clinical Management Workshop 4
New approaches to molecular diagnosis
J Achermann
London, UK
A Allahabadia
Mon 11
14:00
CM1.2
Clinical Management Workshop 1
Thyroid storm, aranulocytosis, vasculitis, hepatitis - what to do next?
A Allahabadia
Bruno Allolio
Würzburg, Germany
Wed 13
11:30
PL4
SOCIETY FOR ENDOCRINOLOGY EUROPEAN MEDAL LECTURE 2010
Adrenal lumps and bumps – progress in the management of adrenocortical tumours
Bruno Allolio
Würzburg, Germany
D Anderson
Montecastello di Vibio, Italy
Thu 14
11:45
SE1.4
SENIOR ENDOCRINOLOGISTS' SESSION
Two seminal case reports of the law breaking the law
D Anderson
Montecastello di Vibio, Italy
R Andrews
Mon 11
12:00
SIG2.3
OBESITY SPECIAL INTEREST GROUP
Pre- and post-operative management of patients undergoing bariatric surgery
R Andrews
B Angelin
Stockholm, Sweden
Wed 13
10:30
S6.4
Symposium 6
Liver-selective TR agonists for the treatment of dyslipidemia
B Angelin
Stockholm, Sweden
W Arlt
Tue 12
09:15
CM2.3
Clinical Management Workshop 2
Adrenal disorders in pregnancy
W Arlt
John Ayuk
Birmingham
Wed 13
15:45
CM3.4
Clinical Management Workshop 3
Radiotherapy, cognition and cerebrovascular disease: what is the evidence?
John Ayuk
Birmingham
L Bartalena
Varese, Italy
Mon 11
14:30
CM1.3
Clinical Management Workshop 1
The management of Graves' opthalmopathy and dermopathy
L Bartalena
Varese, Italy
J Barth
Mon 11
12:30
SIG3.4
LABORATORY ASPECTS OF CLINICAL ENDOCRINOLOGY (LACE) SPECIAL INTEREST GROUP
Definition of hyperandrogenism
J Barth
A Bartke
Springfield, USA
Tue 12
14:00
S4.1
Symposium 4
The aging process - somatotrophic axis and calorie restriction
A Bartke
Springfield, USA
D Bassett
Wed 13
09:00
S6.1
Symposium 6
Thyroid hormone action - genomic and non-genomic effects
D Bassett
Philip Beales
London, UK
Tue 12
16:30
S5.1
Symposium 5
Primary cilia in health and disease
Philip Beales
London, UK
G Beckett
Mon 11
12:00
SIG3.3
LABORATORY ASPECTS OF CLINICAL ENDOCRINOLOGY (LACE) SPECIAL INTEREST GROUP
Definition of hypothyroidism
G Beckett
P Belchetz
Thu 14
11:25
SE1.3
SENIOR ENDOCRINOLOGISTS' SESSION
An exploration of colour theory
P Belchetz
X Bertagna
Paris, France
Wed 13
11:30
PL5
SOCIETY FOR ENDOCRINOLOGY EUROPEAN MEDAL LECTURE 2011
Adrenal interlinking in Europe
X Bertagna
Paris, France
J Bevan
Thu 14
09:00
PL9
CLINICAL ENDOCRINOLOGY TRUST LECTURE
Pituitary tumours: the goal is shrinking
J Bevan
M Bono
Tue 12
14:00
YE1.1
Young Endocrinologists' Symposium
Research in clinical academia
M Bono
M Brada
Wed 13
14:15
CM3.1
Clinical Management Workshop 3
Fractionated RT: efficacy and recent advances
M Brada
T Carpenter
New Haven, USA
Mon 11
11:30
SIG1.2
BONE AND MINERAL SPECIAL INTEREST GROUP
Hypophosphataemic rickets
T Carpenter
New Haven, USA
H Chalal
Mon 11
18:40
YEP1.2
YOUNG ENDOCRINOLOGISTS' PRIZE LECTURES
Clinical, genetic and molecular characterisation of patients with familial isolated pituitary
H Chalal
S Chan
Tue 12
08:15
CM2.1
Clinical Management Workshop 2
Hypothyroidism and euthyroid antibody-positive patients
S Chan
I Clarke
Melbourne, Australia
Wed 13
10:00
S7.3
Symposium 7
Metabolic regulation of the reproductive axis
I Clarke
Melbourne, Australia
H Cleaver
Wed 13
10:20
N1.3
Nurses Session 1
Living with TS: an adult viewpoint
H Cleaver
M Clementi
Padova, Italy
Tue 12
08:45
CM2.2
Clinical Management Workshop 2
Treatment of hyperthyroidism in pregnancy-risk for the unborn
M Clementi
Padova, Italy
R Coleman
Wed 13
15:45
S8.4
Symposium 8
Protecting bone density during aromatase inhibitor therapy
R Coleman
G Conway
Wed 13
09:00
N1.1
Nurses Session 1
Turners/Klinefelters/Noonans Syndrome
G Conway
Thu 14
11:45
CM4.3
Clinical Management Workshop 4
Transitional care of the young person with DSD
G Conway
S Cook
Wed 13
10:40
N1.4
Nurses Session 1
Klinefelter's Syndrome Association
S Cook
M Cooper
Mon 11
12:00
SIG1.3
BONE AND MINERAL SPECIAL INTEREST GROUP
Osteogenesis imperfecta
M Cooper
P Davis
New York, USA
Wed 13
10:00
S6.3
Symposium 6
The action of thyroid hormone in vascular tissues
P Davis
New York, USA
C Dayan
Mon 11
15:00
CM1.4
Clinical Management Workshop 1
New therapies for Graves' Disease
C Dayan
S Ellard
Mon 11
14:00
S1.2
Symposium 1
The diverse phenotypes of potassium ATP channel mutations
S Ellard
J Fagin
Thu 14
08:30
PL8
CLINICAL ENDOCRINOLOGY TRUST VISITING PROFESSOR LECTURE
Genetics of thyroid cancer: clinical and therapeutic implications
J Fagin
J Franklyn
Wed 13
14:15
N2.1
Nurses' Session 2
Overview of causes and treatment options
J Franklyn
B Fraser
Tue 12
16:30
D1.2
Clinical Debate
This house believes there is an important role for bone markers in the clinical management of patients with osteoporosis
B Fraser
P Friedl
Nijmegen, Netherlands
Mon 11
14:10
AP1.2
Applied Physiology Workshop
Imaging of cell migration and invasion
P Friedl
Nijmegen, Netherlands
T Friedmann
San Diego, USA
Thu 14
12:15
S9.4
Symposium 9
Detection: gene and cellular technologies
T Friedmann
San Diego, USA
P Fuller
Melbourne, Australia
Tue 12
PL2
SOCIETY FOR ENDOCRINOLOGY HOFFENBERG INTERNATIONAL MEDAL LECTURE
Aldosterone action and the mineralocorticoid receptor
P Fuller
Melbourne, Australia
C Gregson
Mon 11
11:00
SIG1.1
BONE AND MINERAL SPECIAL INTEREST GROUP
Osteopetrosis and other causes of high bone mass
C Gregson
A Hanyaloglu
Tue 12
15:00
YE1.3
Young Endocrinologists' Symposium
Postdoctoral research - the things I wish I knew
A Hanyaloglu
P Hemmersbach
Oslo, Norway
Thu 14
11:15
S9.2
Symposium 9
Compounds enhancing oxygen delivery
P Hemmersbach
Oslo, Norway
O Hiort
Lubeck, Germany
Thu 14
11:15
CM4.2
Clinical Management Workshop 4
Presentation in adolescence
O Hiort
Lubeck, Germany
D Hochhauser
Mon 11
17:30
S2.4
Symposium 2
New horizons in therapy
D Hochhauser
L Hofbauer
Dresden, Germany
Wed 13
14:15
S8.1
Symposium 8
Fracture risk in patients with diabetes
L Hofbauer
Dresden, Germany
R Holt
Thu 14
11:45
S9.3
Symposium 9
Growth hormone
R Holt
I Hughes
Thu 14
10:45
CM4.1
Clinical Management Workshop 4
The clinical spectrum of DSD
I Hughes
D Johnson
Mon 11
12:30
SIG2.4
OBESITY SPECIAL INTEREST GROUP
Bariatric surgery - a cure for diabetes?
D Johnson
J Kaufman
Gent, Belgium
Wed 13
15:15
S8.3
Symposium 8
Effects of male hypogonadism on bone metabolism
J Kaufman
Gent, Belgium
A Kicman
Thu 14
10:45
S9.1
Symposium 9
Anabolic steroids
A Kicman
M Kidd
New Haven, USA
Mon 11
16:00
S2.1
Symposium 2
Signalling pathways in neuroendocrine tumours
M Kidd
New Haven, USA
P King
Tue 12
17:00
S5.2
Symposium 5
The importance of primary cilia in adrenal development
P King
J Kopchick
Tue 12
18:30
PL3
SOCIETY FOR ENDOCRINOLOGY TRANSATLANTIC MEDAL
Growth hormone (GH), GH antagonists, GH receptor knockouts; getting old and fat
J Kopchick
J Lenders
Nijmegen, Netherlands
Tue 12
09:45
CM2.4
Clinical Management Workshop 2
Phaeochromocytoma in pregnancy
J Lenders
Nijmegen, Netherlands
W Lichtenbelt
Maastrict, Netherlands
Tue 12
08:15
S3.1
Symposium 3
Can we make more brown adipose tissue to treat obesity?
W Lichtenbelt
Maastrict, Netherlands
J Lord
Tue 12
15:00
S4.3
Symposium 4
DHEA, DHEAS and immunosenescence
J Lord
M Ludwig
Wed 13
09:00
S7.1
Symposium 7
Vasopressin and social bonding: the role of the olfactory bulb
M Ludwig
A MacLullich
Tue 12
15:30
S4.4
Symposium 4
Aging, hormones and cognition in humans
A MacLullich
S Mahajan
Mon 11
14:50
AP1.3
Applied Physiology Workshop
CARS microscopy as a novel tool in cell imaging
S Mahajan
V Marion
Strasbourg, France
Tue 12
17:30
S5.3
Symposium 5
The importance of primary cilia in adipogenic differentiation
V Marion
Strasbourg, France
T Masud
Wed 13
14:45
S8.2
Symposium 8
Muscle weakness, falls and vitamin D deficiency
T Masud
L Matthews
Mon 11
18:10
YEP1.1
YOUNG ENDOCRINOLOGISTS' PRIZE LECTURES
Novel glucocorticoid effects - signaling from the membrane to the nucleus
L Matthews
A McLellan
Tue 12
16:30
D1.1
Clinical Debate
This house believes there is an important role for bone markers in the clinical management of patients with osteoporosis
A McLellan
A McNeilly
Tue 12
14:30
YE1.2
Young Endocrinologists' Symposium
Managing your research degree
A McNeilly
P Mollard
Montpellier, France
Mon 11
13:30
AP1.1
Applied Physiology Workshop
Cellular imaging in the pituitary - in vivo confocal microscopy
P Mollard
Montpellier, France
V Navarro
Washington, USA
Wed 13
10:30
S7.4
Symposium 7
Neurokinin B, kisspeptin and the regulation of puberty
V Navarro
Washington, USA
E Nieschlag
Muenster, Germany
Thu 14
10:45
SE1.1
SENIOR ENDOCRINOLOGISTS' SESSION
The metamorphosis of testosterone from a sex steroid to a universal health factor
E Nieschlag
Muenster, Germany
T Olbers
Mon 11
11:30
SIG2.2
OBESITY SPECIAL INTEREST GROUP
Gut, hormones, weight loss and metabolic improvement after bariatric surgery
T Olbers
K Owen
Mon 11
14:30
S1.3
Symposium 1
Using biomarkers to differentiate subtypes of MODY
K Owen
D Papadopoulou
Wed 13
15:45
N2.4
Nurses' Session 2
Hyperthyroidism
D Papadopoulou
S Pearce
Newcastle, UK
Mon 11
13:30
CM1.1
Clinical Management Workshop 1
Autoimmune hyperthyroidism - a spectrum of causes
S Pearce
Newcastle, UK
D Perez-Tilve
Cincinatti, USA
Mon 11
11:00
SIG2.1
OBESITY SPECIAL INTEREST GROUP
Gut hormone based polypharmacy - same benefits without the surgery?
D Perez-Tilve
Cincinatti, USA
J Perry
Mon 11
15:00
S1.4
Symposium 1
Genome-wide association studies for Type 2 diabetes
J Perry
P Pickett
Wed 13
10:00
N1.2
Nurses Session 1
Klinefelter's case presentation
P Pickett
V Plagnol
Mon 11
13:30
S1.1
Symposium 1
Immune mechanisms involved in Type 1 diabetes - insights from genetics
V Plagnol
V Prevot
Lille, France
Wed 13
09:30
S7.2
Symposium 7
The role of tanycytes in the regulation of the reproductive axis
V Prevot
Lille, France
P Rao
Mon 11
16:00
OC1.1
Oral Communications 1
Thyroid hormones in the euthyroid range predict subsequent body mass composition in women - the OPUS study
P Rao
S Refetoff
Chicago, USA
Wed 13
18:00
PL7
BRITISH THYROID ASSOCIATION PITT-RIVERS LECTURE
An expanded view on resistance to thyroid hormone
S Refetoff
Chicago, USA
J Rowe
Wed 13
14:45
CM3.2
Clinical Management Workshop 3
Focussed radiotherapy as primary treatment for pituitary disease
J Rowe
V Sanderson
Wed 13
14:45
N2.2
Nurses' Session 2
Nurse led thyroid clinic
V Sanderson
T Scanlan
Portland, USA
Wed 13
09:30
S6.2
Symposium 6
Physiology and pharmacology of iodothyronamines (thyroid hormone metabolites)
T Scanlan
Portland, USA
C Selman
Tue 12
14:30
S4.2
Symposium 4
Mechanisms: insulin sensitivity, AMPK and lifespan
C Selman
Robert Semple
Edinburgh, UK
Tue 12
09:15
S3.3
Symposium 3
The link between insulin resistance, dyslipidaemia and fatty liver
Robert Semple
Edinburgh, UK
V Sheffield
Iowa City, USA
Tue 12
18:00
S5.4
Symposium 5
Primary cilia dysfunction causes impaired leptin signalling and obesity
V Sheffield
Iowa City, USA
C Shoulders
Tue 12
09:45
S3.4
Symposium 3
What you need to know about the genetics of hyperlipidaemia
C Shoulders
E Simpson
Melbourne, Australia
Tue 12
PL1
SOCIETY FOR ENDOCRINOLOGY DALE MEDAL LECTURE
Aromatase, obesity and breast cancer - old wine in new bottles
E Simpson
Melbourne, Australia
S Suliman
Tue 12
08:45
S3.2
Symposium 3
Familial partial lipodystrophy - an introduction and the importance of diagnosing FPLD
S Suliman
F Swords
Wed 13
15:15
CM3.3
Clinical Management Workshop 3
Focussed radiotherapy as salvage treatment for pituitary disease
F Swords
J Tata
Thu 14
11:05
SE1.2
SENIOR ENDOCRINOLOGISTS' SESSION
Will we ever discover the mechanism of hormone action?
J Tata
C Thirwell
Mon 11
16:30
S2.2
Symposium 2
DNA methylation profiling of neuroendocrine tumours
C Thirwell
A Toft
Thu 14
12:05
SE1.5
SENIOR ENDOCRINOLOGISTS' SESSION
The art of medicine
A Toft
A Uitterlinden
Rotterdam, Netherlands
Mon 11
12:30
SIG1.4
BONE AND MINERAL SPECIAL INTEREST GROUP
Osteoporosis
A Uitterlinden
Rotterdam, Netherlands
J Valle
Mon 11
17:00
S2.3
Symposium 2
Tyrosine kinase inhibitors for neuroendocrine tumours
J Valle
G Vinson
Thu 14
12:25
SE1.6
SENIOR ENDOCRINOLOGISTS' SESSION
The endocrinology of extra-marital affairs
G Vinson
J Walsh
Mon 11
11:00
SIG3.1
LABORATORY ASPECTS OF CLINICAL ENDOCRINOLOGY (LACE) SPECIAL INTEREST GROUP
Definition of Vitamin D deficiency
J Walsh
C Wang
Torrence, USA
Mon 11
11:30
SIG3.2
LABORATORY ASPECTS OF CLINICAL ENDOCRINOLOGY (LACE) SPECIAL INTEREST GROUP
Definition of male hypogonadism
C Wang
Torrence, USA
J Wass
Thu 14
09:30
CG1.1
CLINICAL GUIDELINES
Management of pituitary apoplexy
J Wass
S Webster
Tue 12
15:30
YE1.4
Young Endocrinologists' Symposium
Commercialisation and IP – translating scientific research
S Webster
G Williams
Wed 13
16:45
PL6
SOCIETY FOR ENDOCRINOLOGY MEDAL LECTURE
The bare bones of thyroid hormones
G Williams
D Wright
Wed 13
15:15
N2.3
Nurses' Session 2
Case presentation
D Wright
Workshop
0
Oral
0
Expert
0
Plenary
0
Catering and Social
0
Nurse
0
Other
0
Symposium
8
Mon 11
13:30
Symposium 1
ALL YOU NEED TO KNOW ABOUT THE GENETICS OF DIABETES (TYPE 1 & 2 AND MODY)
HALL 11
Chairs: S Farooqi (Cambridge) & S Finer (London)
Mon 11
13:30
S1.1
Symposium 1
Immune mechanisms involved in Type 1 diabetes - insights from genetics
V Plagnol
Mon 11
14:00
S1.2
Symposium 1
The diverse phenotypes of potassium ATP channel mutations
S Ellard
Mon 11
14:30
S1.3
Symposium 1
Using biomarkers to differentiate subtypes of MODY
K Owen
Mon 11
15:00
S1.4
Symposium 1
Genome-wide association studies for Type 2 diabetes
J Perry
Mon 11
16:00
Symposium 2
NOVEL PATHWAYS AND TREATMENTS IN NEUROENDOCRINE TUMOURS
SUPPORTED BY THE ASSOCIATION FOR MULTIPLE ENDOCRINE NEOPLASIA DISORDERS
HALL 11
Chairs: P Trainer (Manchester) & U Srirangalingam (London)
Mon 11
16:00
S2.1
Symposium 2
Signalling pathways in neuroendocrine tumours
M Kidd
New Haven, USA
Mon 11
16:30
S2.2
Symposium 2
DNA methylation profiling of neuroendocrine tumours
C Thirwell
Mon 11
17:00
S2.3
Symposium 2
Tyrosine kinase inhibitors for neuroendocrine tumours
J Valle
Mon 11
17:30
S2.4
Symposium 2
New horizons in therapy
D Hochhauser
Tue 12
08:15
Symposium 3
FAT ENDOCRINOLOGY: DISORDERS OF ADIPOSE TISSUE AND LIPIDS IMPORTANT TO THE ENDOCRINOLOGIST
HALL 1
Chairs: W Dhillo (London) & A Sam (London)
Tue 12
08:15
S3.1
Symposium 3
Can we make more brown adipose tissue to treat obesity?
W Lichtenbelt
Maastrict, Netherlands
Tue 12
08:45
S3.2
Symposium 3
Familial partial lipodystrophy - an introduction and the importance of diagnosing FPLD
S Suliman
Tue 12
09:15
S3.3
Symposium 3
The link between insulin resistance, dyslipidaemia and fatty liver
Robert Semple
Edinburgh, UK
Tue 12
09:45
S3.4
Symposium 3
What you need to know about the genetics of hyperlipidaemia
C Shoulders
Tue 12
14:00
Symposium 4
ENDOCRINE REGULATION OF AGEING
HALL 10
Chairs: J Kopchick (Athens, GA, USA) & C Moss (London)
Tue 12
14:00
S4.1
Symposium 4
The aging process - somatotrophic axis and calorie restriction
A Bartke
Springfield, USA
Tue 12
14:30
S4.2
Symposium 4
Mechanisms: insulin sensitivity, AMPK and lifespan
C Selman
Tue 12
15:00
S4.3
Symposium 4
DHEA, DHEAS and immunosenescence
J Lord
Tue 12
15:30
S4.4
Symposium 4
Aging, hormones and cognition in humans
A MacLullich
Tue 12
16:30
Symposium 5
THE NOVEL ROLE OF PRIMARY CILIA IN ENDOCRINE DISEASE AND OBESITY
HALL 9
Chairs: P Chapple (London) & L Guasti (London)
Tue 12
16:30
S5.1
Symposium 5
Primary cilia in health and disease
Philip Beales
London, UK
Tue 12
17:00
S5.2
Symposium 5
The importance of primary cilia in adrenal development
P King
Tue 12
17:30
S5.3
Symposium 5
The importance of primary cilia in adipogenic differentiation
V Marion
Strasbourg, France
Tue 12
18:00
S5.4
Symposium 5
Primary cilia dysfunction causes impaired leptin signalling and obesity
V Sheffield
Iowa City, USA
Wed 13
09:00
Symposium 6
NOVEL APPLICATION OF THYROID HORMONE ANALOGUES - THYROID HORMONES, THINKING OUTSIDE THE CAPSULE
HALL 11
Chairs: M Vanderpump (London) & V Smith (Birmingham)
Wed 13
09:00
S6.1
Symposium 6
Thyroid hormone action - genomic and non-genomic effects
D Bassett
Wed 13
09:30
S6.2
Symposium 6
Physiology and pharmacology of iodothyronamines (thyroid hormone metabolites)
T Scanlan
Portland, USA
Wed 13
10:00
S6.3
Symposium 6
The action of thyroid hormone in vascular tissues
P Davis
New York, USA
Wed 13
10:30
S6.4
Symposium 6
Liver-selective TR agonists for the treatment of dyslipidemia
B Angelin
Stockholm, Sweden
Wed 13
09:00
Symposium 7
EAT, BOND, REPRODUCE, WHAT THE HYPOTHALAMUS DICTATES
HALL 1
Chairs: G Leng (Edinburgh) & C Jayasena (London)
Wed 13
09:00
S7.1
Symposium 7
Vasopressin and social bonding: the role of the olfactory bulb
M Ludwig
Wed 13
09:30
S7.2
Symposium 7
The role of tanycytes in the regulation of the reproductive axis
V Prevot
Lille, France
Wed 13
10:00
S7.3
Symposium 7
Metabolic regulation of the reproductive axis
I Clarke
Melbourne, Australia
Wed 13
10:30
S7.4
Symposium 7
Neurokinin B, kisspeptin and the regulation of puberty
V Navarro
Washington, USA
Wed 13
14:15
Symposium 8
HORMONES AND BONE METABOLISM
HALL 11
Chairs: S Orme (Leeds) & M Aye (Kingston-upon-Hull)
Wed 13
14:15
S8.1
Symposium 8
Fracture risk in patients with diabetes
L Hofbauer
Dresden, Germany
Wed 13
14:45
S8.2
Symposium 8
Muscle weakness, falls and vitamin D deficiency
T Masud
Wed 13
15:15
S8.3
Symposium 8
Effects of male hypogonadism on bone metabolism
J Kaufman
Gent, Belgium
Wed 13
15:45
S8.4
Symposium 8
Protecting bone density during aromatase inhibitor therapy
R Coleman
No Session Type
3
Mon 11
13:00
LUNCH
HALL 3
Mon 11
15:30
TEA & COFFEE
HALL 3
Tue 12
07:00
Breakfast
HALL 9, 10 & 11 FOYER
0 result(s) found.
Please wait...
×
-
×
Abstracts from this event
Abstracts from other events
Session starts at:
Abstract time:
Event:
×